Product
SSKI
2 clinical trials
3 indications
Indication
MedulloblastomaIndication
EpendymomaIndication
Graves diseaseClinical trial
Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients With Recurrent Medulloblastoma and EpendymomaStatus: Active (not recruiting), Estimated PCD: 2029-10-30
Clinical trial
Does the Use of Pre-operative SSKI Actually Reduce Vascularity and Improve Surgical Outcomes for Total Thyroidectomy in Graves' Disease?Status: Completed, Estimated PCD: 2023-03-03